Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00465855
Status:
COMPLETED
Last Update Posted:
2021-02-12
First Post:
2007-04-23
Brief Title:
One vs Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning
Sponsor:
Intermountain Health Care Inc
Organization:
Intermountain Health Care Inc
Study Overview
Official Title:
Randomized Trial of One Versus Three Hyperbaric Oxygen Treatments for Acute CO Poisoning
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
1V3CORCT
Brief Summary:
This randomized trial will investigate important clinical outcomes of patients with acute carbon monoxide poisoning randomized to receive either one or three hyperbaric oxygen treatments
Detailed Description:
All patients presenting with acute carbon monoxide poisoning will receive one hyperbaric oxygen treatment barring contraindications for hyperbaric oxygen therapy After this treatment eligible patients who provide consent will be randomly allocated to receive two sham sessions or two additional hyperbaric oxygen sessions administered in a double-blind fashion
Outcome measures will be administered at 6 weeks and 6 months
Outcome measures will be administered at 6 weeks and 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None